Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 6689 - 6696 of 12008 results

Health Care Weekly Preview from ML Strategies – Week of September 11, 2017
September 12, 2017| Blog| Viewpoint

Equifax Breach: Three Takeaways from the First Four Days
September 12, 2017| Alert| Viewpoint

Travel Ban Allowed to Exclude Certain Refugees – For Now
September 12, 2017| Alert| Viewpoint

Things We've Learned As The PTAB Turns 5
September 12, 2017| News

Baker-Polito Administration Awards $455,000 in Grants to Clean Energy Innovators
September 11, 2017| Blog| Viewpoint

FDA Takes First Steps to Cut Regulations, Solicits Public Feedback
September 11, 2017| Blog| Viewpoint

Washington State AG Alleges Price Fixing and Sues to Break Up Rapidly Expanding Health System
September 11, 2017| Alert| Viewpoint

Reminder – New Form I-9
September 8, 2017| Alert| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|

Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|
